Browse drugs

…I von Willebrand disease with an inhibitor, in which the use of emicizumab yielded promising clinical outcomes.Aim and Objectives To evalu…

…round and Importance There is a growing interest in intravenous vancomycin therapy supported by therapeutic drug monitoring (TDM). In addi…

…oduction Since July 2019, the WHO has recommended dolutegravir (DTG)-based regimens as preferred first-line antiretroviral therapy …

…nation of patients with history of LN versus non-renal SLE, but Orgentec displayed good discrimination for patients with active LN from …

…olone 2 mg/kg for at least 72 hours and underwent liver biopsy. Ursodeoxycholic acid was added in mixed and cholestatic drug-induced liver injury (D…

… Adverse events were almost exclusively in Arm 3, attributed to nivolumab. One patient achieved MRD (Arm 2), and three patients had an RC…

… with IgG4-RD and 10 healthy individuals, all of whom underwent [ 18F]FAPI PET/CT. Organ-specific uptake thresholds were defined as [18F]F…

…val in relapse models with antigen downregulation. Furthermore, ARI2h-TM28 showed an optimized metabolic profile, more oxidative and energ…

…ed effects on hepatocyte function. In vitro studies showed that TBOEP promotes lipid accumulation in hepatocytes by increasing PPARγ …

…d clinical domains, known to be linked to damage accrual, makes aPS/PT a tool for risk stratification in APS.…

…topenias, high-titer ANA and anti-dsDNA led to SLE diagnosis so hydroxychloroquine and glucocorticoid were started. In 2014, due to high proteinur…

…I was 0 (0-1.25). Standard treatments during pregnancy included prednisone (83%), antimalarials (86%), azathioprine (47%); calcineurin-inh…